New York, New York – July 30, 2012 - Investorideas.com (www.Investorideas.com ) , an investor research portal specializing in sector research including biotech and pharma stocks, issues CFA commentary by Patrick J. Murphy of Murphy Analytics LLC, on Sunshine Biopharma Inc. (OTCBB: SBFM) and its lead anti-cancer compound, Adva-27a.
READ MORE AT:
www.investorideas.com






Add new comment